Gynecologic oncology focuses on cancers of the female reproductive system and integrates prevention, screening, surgery, systemic therapy, radiation, molecular diagnostics, and hereditary cancer management. This session highlights clinical and scientific advances aimed at improving outcomes across gynecologic malignancies.
Abstract Scope and Participation
Abstracts may cover ovarian, cervical, endometrial, uterine, vulvar, vaginal, and related cancers, including hereditary risk, biomarkers, surgery, chemotherapy, targeted therapy, immunotherapy, radiation, and survivorship. Gynecologic oncologists, researchers, surgeons, pathologists, geneticists, and allied professionals are encouraged to participate.







Title : Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States